In melanoma cell lines, exogenous p53β was found to enhance p53 target gene expression in response to chemotherapeutic treatment with cisplatin, while Δ40p53 was found to impair the upregulation of the same p53 target genes following cisplatin treatment [17]. Here, TP53 is linked to melanoma.